News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Take multiple biopsies in studies of personalised breast cancer treatments, study says
New research finds taking single biopsy can miss key genetic mutations that could influence drug susceptibility and resistance
Dr Andrea Sottoriva wins Cancer Research UK Future Leaders in Cancer Research Prize
Dr Andrea Sottoriva has been awarded a Cancer Research UK Future Leaders in Cancer Research Prize at this year’s National Cancer Research Institute (NCRI) Conference in Liverpool.
-by-max-westby-creative-commons-by-nc-sa.jpg?sfvrsn=e03bccc1_2 "Fruit fly (Drosophila melanogaster, male), by Max Westby / Creative Commons BY-NC-SA")
Relish is pickled to protect flies from immunogenic havoc
Two proteins called Pickle and Relish help to keep fruit flies healthy, a new study shows.
ICR launches new PhD recruitment drive
The Institute of Cancer Research, London, has begun its annual drive to recruit the best and brightest PhD students, as advertisements for 12 fully funded research projects go live.
New drug combination could target incurable infant cancer
Scientists have identified a drug combination that could be effective against a childhood cancer for which there is no current cure.
Promising drug target for aggressive ‘triple-negative’ breast cancers identified
Scientists have identified a molecule crucial to the growth of triple-negative breast cancers that they believe could now be targeted by drugs to help treat patients resistant to chemotherapy.
Secondary breast and bowel cancers found to grow by piggy-backing on patients’ blood vessels
New research into breast and bowel cancers that have spread to the liver shows that some tumours power their growth using pre-existing blood vessels rather than developing new ones.
Statement about ABPI report into the changing UK drug discovery landscape
The Institute of Cancer Research, London, has issued the following statement from Chief Executive Professor Paul Workman in response to a new report by the Association of the British Pharmaceutical Industry (ABPI) on the changing UK drug discovery landscape.
.jpg?sfvrsn=a198af27_2 "Deformed cells in the bone marrow, typical of chronic leukaemia (photo: Difu Wu)")
Overcoming the evolution of cancer
Cancer evolution can lead to the emergence of drug resistance, so the ICR and The Royal Marsden are working to unravel cancer's complexity and open up new approaches to treatment.
Faulty molecule offers new target for treating liver cancer
Blocking a single faulty molecule in a biological process that drives the growth of advanced liver cancers could offer a new way to treat the disease, researchers have found.
2D building blocks can build better 3D drugs
Creating cancer drugs that better resemble 3D structures in cells is all about how you put the building blocks together, a new study has shown.
Quarter-of-a-million-pound ICR fundraiser needs your vote for JustGiving Awards
Bowel cancer patient and fundraiser Tim Morgan has been nominated for JustGiving’s Fundraising Team of the Year award after raising more than £250,000 for the ICR — and he needs your vote!
